Covista Inc. (CVSA)
NYSEConsumer DiscretionaryEducation & Training ServicesSnapshot 2026-09-04
$128.09+0.35%
Close 2026-09-04 · 1-day change
NYSEConsumer DiscretionaryEducation & Training ServicesSnapshot 2026-09-04
QuarterlyIQ Insights · CVSA
How strong the business is — where it ranks within its sector on capital efficiency and cash generation, and how well management has been executing.
How this business ranks within consumer discretionary on a research-validated quality screen. As of 2026-09-04.
The screen ranks CVSA against its sector on four durable signals: share dilution, return on capital, free-cash-flow yield, and FCF margin. Historically the highest-quality names tended toward better typical outcomes and fewer bad years over multi-year holds (strongest at three years, modest at one), and that pattern showed up even before the price moved. It characterizes business quality, not price direction.
Each leg is a sector-relative percentile (higher is better); 4 of 4 legs were available for this name. The composite is built from these four; the raw value follows each percentile for context.
A forward quality tilt, not a price prediction, and context for your own research rather than a recommendation. Not investment advice.
How management runs the business: capital, margins, balance sheet, and how reliably they guide and deliver.
Each factor is a parallel diagnostic with a clear read of what it shows and how names like it have historically fared. Never aggregated into a single score.
Operating income rose in 2 of the last 3 quarter-over-quarter moves. Historically, Consumer Discretionary names rated neutral grew net income 45% of the time over the next year (vs 59% for the rest of the cohort, n=6943).
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
A guidance track record builds as the company issues and delivers on guidance.
Priorities management has stated in recent disclosures, with status and evidence drawn from earnings calls, filings, and press releases.
Raise fiscal year 2026 revenue guidance to $1.93B-$1.945B and adjusted EPS guidance to $7.95-$8.15, reflecting growth of approximately 8%-9% and 19%-22% respectively.
Stated as a priority in 3 of last 3 quarters. Covista raised its fiscal year 2026 revenue guidance from $1,900 million-$1,940 million to $1,930 million-$1,945 million, reflecting 8%-9% growth, and adjusted EPS guidance from $7.80-$8.00 to $7.95-$8.15, reflecting 19%-22% growth. The trajectory matches management's stated commitment to growth and guidance increases.
“Covista raised its revenue guidance for fiscal year 2026 from $1,900 million-$1,940 million to $1,930 million-$1,945 million, and adjusted EPS from $7.80-$8.00 to $7.95-$8.15.”
“Increased fiscal year 2026 guidance: revenue $1,930 million to $1,945 million, adjusted EPS $7.95 to $8.15.”
“Covista raised its revenue guidance for fiscal year 2026 from $1,900 million-$1,940 million to $1,930 million-$1,945 million, and adjusted EPS from $7.80-$8.00 to $7.95-$8.15.”
Advance the Purpose at Scale strategy by extending Covista's platform into new healthcare areas to address workforce shortages and create durable demand for graduates.
Stated as a priority in 2 recent disclosures without specific quarterly fiscal_period. Management articulated the Purpose at Scale strategy emphasizing platform expansion into adjacent healthcare domains. While no direct financial metrics are cited, this strategic priority is newly emphasized and aligns with the company's growth narrative.
Develop deep partnerships with healthcare systems to create proprietary workforce pipelines that drive enrollment and connect graduates directly to employment.
Stated as a priority in 2 recent disclosures without specific fiscal_period. Management emphasizes employer integration to build workforce pipelines with healthcare partners, addressing talent shortages. This strategic focus is consistent with the Purpose at Scale growth framework but lacks direct financial metrics in the provided data.
Leverage AI technology to enhance healthcare education through new professional certificates and AI fluency programs across Covista's institutions.
Stated as a priority in 2 of last 3 quarters. Covista expanded AI-enabled healthcare education certificates from over 4,000 learners enrolled in 2026-Q1 to more than 9,000 learners by 2026-Q3. This demonstrates delivery on the AI innovation priority with growing adoption of new programs.
“Covista added nine new AI professional certificates, enrolling more than 9,000 learners to date.”
Sustain operational discipline to convert healthcare demand into profitable growth, focusing on enrollment growth, operating income, and cost management.
Stated as a priority in 3 of last 3 quarters. Covista's revenue increased from $1,788 million in fiscal 2025 to $1,954 million in fiscal 2026, with operating income rising from $342 million to $383 million. This reflects delivery on operational excellence with growth in top-line and profitability consistent with management's stated focus.
“Purpose at Scale powered by an operating model that converts durable healthcare demand into sustainable, profitable growth.”
Over the trailing year it converted 2.60x of net income into operating cash flow. Historically, Consumer Discretionary names rated robust grew net income 58% of the time over the next year (vs 45% for the rest of the cohort, n=3652).
Not enough signal yet.
Not enough signal to read sensitivity to the broad stock market, the US dollar, Fed net liquidity, real (inflation-adjusted) rates, long-term interest rates (low R² over the window).
11 material management or governance events in the past 24 months, led by capital-allocation actions. Historically, Consumer Discretionary names rated neutral grew net income 48% of the time over the next year (vs 53% for the rest of the cohort, n=2538).
Not investment advice. As of 2026-09-04.
“Covista launched healthcare-specific AI professional certificates with Google Cloud, enrolling more than 4,000 learners.”
“Executing Growth with Purpose strategy with relentless focus on student outcomes and compounding returns.”
“Covista continues to execute on Growth with Purpose strategy, leading transformation of healthcare education.”